CLINICAL_TRIALS
trial_result
· 2017-04-26
Clinical Trial Update: NAVISTAR® THERMOCOOL® Catheter Post Approval Registry [Phase 4]
Summary
Phase 4 post-approval registry of the NAVISTAR ThermoCool catheter for paroxysmal atrial fibrillation. The study status is completed with results posted in 2017…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biosense Webster, Inc. | Conditions: Paroxysmal Atrial Fibrillation | Phase 4 | Status: COMPLETED | Results posted: 2017-04-26